(Q44022379)

29 November 2017

Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells (English)

1 reference

29 November 2017

Mingui Fu

1

1 reference

29 November 2017

Jifeng Zhang

2

1 reference

29 November 2017

Yimin g Lin Yg

3

1 reference

29 November 2017

Xiaojun Zhu

4

1 reference

29 November 2017

Timothy M Willson

5

1 reference

29 November 2017

Yuqing E Chen

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Biochemical and Biophysical Research Communications

29 November 2017

1 reference

29 November 2017

294

1 reference

29 November 2017

3

1 reference

29 November 2017

597-601

1 reference

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Orphan nuclear receptors: shifting endocrinology into reverse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Peroxisome proliferator-activated receptor gamma and metabolic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Peroxisome proliferator-activated receptors in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

The PPARs: from orphan receptors to drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Osteoprotegerin: a link between osteoporosis and arterial calcification?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Bone morphogenetic protein expression in human atherosclerotic lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900533-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-291X(02)00533-8

1 reference

29 November 2017

1 reference